March 7, 2016
Second Indication for Ibrance
IBRANCE (palbociclib) was recently granted F.D.A.-approval for a second indication.
IRBANCE is a limited distribution oral oncology medication approved for use in certain types of breast cancer patients. As a limited distribution medication, IBRANCE is only available from a handful of select pharmacies
Onco360 has access to IBRANCE and the product is immediately available for prescription order. Order IBRANCE now.
For more information visit our IBRANCE page.